Equine Grass Sickness vaccine trial
Welcome to the EGS Vaccine Trial website. Scientific evidence suggests that the bacterium Clostridium botulinum type C plays a role in causing EGS. The EGS vaccine trial has been designed to determine whether vaccination against Clostridium botulinum type C reduces the risk of EGS.
Recruitment for the vaccine trial has now closed. However, researchers will continue to follow and collect data from all enrolled horses and ponies over the next year. We would like to take this opportunity to thank everyone who has supported the EGS vaccine trial so far. You can still find our more information on this ground-breaking trial by following the links below.
ABOUT THE EGS VACCINE TRIAL
Find out more about the EGS vaccine trial.
FREQUENTLY ASKED QUESTIONS
Our owner information pack for comprehensive details about the EGS Vaccine Trial and what's involved in taking part.
Find out more
The EGS vaccine trial would not be possible without generous funding from a number of organisations and individuals.